COACH-Cog Intervention Adaptation Focus Groups

July 17, 2023 updated by: Allison Magnuson, University of Rochester

Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision - Focus Groups

To gather key stakeholder input for feedback on the adaption of the COACH GA intervention (i.e., develop COACH-Cog) to enhance triadic communication among oncologists, care partners and patients with ADRD.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • United States
    • New York
      • Rochester, New York, United States, 14620
        • Recruiting
        • University of Rochester Wilmot Cancer Institute
        • Contact:
          • Allison Magnuson, DO, MS
        • Contact:
          • Jessica Mortimer

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Focus groups will be conducted with the following stakeholders:

  1. Medical oncologists
  2. Clinicians with expertise in cognitive impairment and dementia
  3. Older patients with cancer
  4. Caregivers of patients with dementia

Description

Inclusion/Exclusion Criteria:

The inclusion and exclusion criteria for participants are that they must be able to consent for themselves and must speak English.

For the medical oncologist focus group, participants must be a medical oncologist.

For the clinicians with expertise in cognitive impairment and dementia focus group, participants must be a clinician that treats patients with cognitive impairment and dementia.

For the older patients with cancer focus group, participants must be older than 65 years of age and have or had cancer.

For the caregivers of patients with dementia focus group, participants must be caregivers of patients with dementia or cognitive impairment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Medical Oncologists
Individuals practicing as medical oncologists or with expertise in medical oncology
Clinicians with expertise in cognitive impairment and dementia
Older patients with cancer
Older patients with cancer or older survivors of patients with cancer
Caregivers of patients with dementia or cognitive impairment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative analysis of focus group audio-recording transcripts. Open coding using content analysis framework will be utilized to assess themes of potential intervention adaptations.
Time Frame: Through study completion - Focus group participation will be a single, one-time episode. Estimated time from consent to participation in focus groups is 3 months or less.
Qualitative data gathered from participants during focus group participation. Focus groups will be audio-recorded and transcribed. Transcribed audio-recordings will be qualitatively analyzed for opportunities and recommendations for further intervention adaptation. Open coding using content analysis framework will be utilized for qualitative analysis.
Through study completion - Focus group participation will be a single, one-time episode. Estimated time from consent to participation in focus groups is 3 months or less.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Rochester

Collaborators

National Institute on Aging (NIA)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2023

Primary Completion (Estimated)

September 30, 2023

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

January 20, 2023

First Submitted That Met QC Criteria

March 7, 2023

First Posted (Actual)

March 20, 2023

Study Record Updates

Last Update Posted (Actual)

July 18, 2023

Last Update Submitted That Met QC Criteria

July 17, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • UOCPC22008
  • R01AG077053 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Focus Groups

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe